Episode

Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases

Podcast
Lung Cancer Update
Published
Aug 22, 2025
Duration seconds
3498
Processing state
not_requested
Canonical source
https://lung-cancer-update.captivate.fm/episode/5556-pp2025-sclc
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/262a4630-4bbf-4bf4-ac7c-bcd840394813.mp3
JSON
/v1/public/podcasts/lung-cancer-update-827388/episodes/small-cell-lung-cancer-expert-perspectives-on-actual-patient-cases
Markdown
/podcast/lung-cancer-update-827388/small-cell-lung-cancer-expert-perspectives-on-actual-patient-cases.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/small-cell-lung-cancer-expert-perspectives-on-actual-patient-cases/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/lung-cancer-update-827388/small-cell-lung-cancer-expert-perspectives-on-actual-patient-cases.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for patients with limited-stage and extensive-stage small cell lung cancer.  CME information and select publications here .